|Articles|February 12, 2016

College Officials Still Don't Know What Has Sickened 174 Students

In just about 24 hours, the number of students at Ursinus College in Collegeville, Pennsylvania experiencing an unidentified stomach illness has increased from 40 to 174.

In just about 24 hours, the number of students at Ursinus College in Collegeville, Pennsylvania experiencing an unidentified stomach illness has increased from 40 to 174.

It all began on the evening of February 9 when multiple students came down with a stomach infection. They experienced symptoms such as prolonged vomiting and some of them sought medical attention at the hospital or urgent cares.

Officials at Ursinus have been investigating the illness alongside the Montgomery County Health Department (MCHD). The dining hall was closed so that the area could be thoroughly cleaned.

To date, it’s still not clear whether the infection is food-borne or transmitted by person-to-person contact. It’s routine to test patients for both bacteria and viruses, but results could take up to a week.

“We will continue to work closely with officials from the Department of Health and follow their recommendations. In addition, Ursinus couldn’t be more grateful for the outpouring of support it has received from the surrounding community to help us support our students,” President Brock Blomberg said in a statement.

A total of 174 students have experienced symptoms of the stomach illness, as of noon on February 11. Out of the 1,681 undergraduates at Ursinus, 96% live on campus or college-operated housing. Officials advise that students use the hot wash and dry cycle when doing laundry and wash their hands after touching soiled clothing.

“I encourage any students or staff experiencing symptoms including diarrhea, vomiting, and abdominal pain to be particularly careful about dehydration and to seek medical care,” advised Valerie Arkoosh, MD, MPH, interim medical director at the MCHD.


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.